Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Rona

Molecular diagnostics firm Great Basin Scientific has appointed Jeffrey Rona as CFO. His appointment went into effect on Oct. 8 in conjunction with the company's initial public offering.

Rona has served as a financial consultant to Great Basin since 2012 in his role as the managing director of Rona Capital, a life sciences-focused transactional advisory consultancy founded in 2011. From 2006 to 2011, Rona was the chief business officer of GlobeImmune. Prior to that, he was vice president of corporate development for Corgentech, following the merger between Corgentech and AlgoRx Pharmaceuticals in 2005. At AlgoRx, he was CFO and responsible for the execution of the merger with Corgentech. Rona has also worked for UBS Warburg, Antigenics (now Agenus), and Coopers and Lybrand.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.